Shmuel Ben Zvi
Fortune : 17 775 $ au 31/07/2026
Fortune : 17 775 $ au 31/07/2026
Shmuel Ben Zvi is currently an Independent Director at Protalix Biotherapeutics, Inc. since 2022, an Independent Non-Executive Director at BATM Advanced Communications Ltd. since 2024, and Manager & Owner of Shmuel (Muli) Ben Zvi Ltd. Formerly, Dr. Ben Zvi was Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd. from 2004 to 2014, Chairman at Bank Leumi Le-Israel B.M.
from 2023 to 2024, Independent Non-Executive Director at Vascular Biogenics Ltd. from 2018 to 2023, Independent Director at Sol-Gel Technologies Ltd. from 2018 to 2023, and Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Education includes undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 7 500 ( 0,01 % ) | 17 775 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/06/2022 |
| BATM ADVANCED COMMUNICATIONS LTD. | Directeur/Membre du Conseil | 19/12/2024 |
Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Président | 28/11/2024 |
| SOL-GEL TECHNOLOGIES LTD. | Directeur/Membre du Conseil | 01/11/2023 |
| NOTABLE LABS, LTD. | Directeur/Membre du Conseil | 16/10/2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/12/2014 |
Israel Ministry of Defense
Israel Ministry of Defense SovereignGovernment Provides national security | Corporate Officer/Principal | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Bank Leumi Le-Israel B.M.
Bank Leumi Le-Israel B.M. Major BanksFinance Provides retail and commercial banking and financial management services | Finance |
BATM Advanced Communications Ltd.
BATM Advanced Communications Ltd. Telecommunications EquipmentElectronic Technology Designs and manufactures data communications equipment for use in local & wide area networks | Electronic Technology |
Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd. Pharmaceuticals: MajorHealth Technology Engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Israel Ministry of Defense
Israel Ministry of Defense SovereignGovernment Provides national security | Government |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Shmuel (Muli) Ben Zvi Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national